<DOC>
	<DOCNO>NCT00473668</DOCNO>
	<brief_summary>The purpose observer-blind study generate immunogenicity data one formulation GSK Biologicals ' DTPw-HBV/Hib vaccine primary vaccination course demonstrate non-inferiority vaccine compare two formulation GSK Biologicals ' DTPw-HBV/Hib vaccine respect anti-PRP antibody response . Additionally assess reactogenicity safety GSK Biologicals ' DTPw-HBV/Hib vaccine . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Non-inferiority GSK Biologicals ' DTPw-HBV/Hib Compared Two Formulations GSK Biologicals ' DTPw-HBV/Hib</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Tetanus</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<criteria>Subjects investigator believe parents/guardians comply requirement protocol enrol study . A male female , include , 6 8 week age time first vaccination . Written inform consent obtain parent guardian subject . Healthy subject establish medical history clinical examination enter study . Born gestation period 36 42 week inclusive . Administration one dose hepatitis B vaccine birth Use investigational nonregistered product ( drug vaccine ) study vaccine ( ) within 30 day precede first dose study vaccine , plan use study period exception OPV . Chronic administration ( defined 14 day ) immunosuppressant immunemodifying drug since birth . Planned administration/ administration vaccine foreseen study protocol period start 30 day administration first vaccine dose , ( exception OPV ) . Bacille CalmetteGu√©rin ( BCG ) vaccine receive first 2 week life . Hepatitis B vaccine receive first week life . Previous vaccination diphtheria , tetanus , pertussis , Haemophilus influenzae hepatitis B ( except hepatitis B birth ) . History diphtheria , tetanus , pertussis , Haemophilus influenzae hepatitis B disease . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination ( laboratory testing require ) . A family history congenital hereditary immunodeficiency . History allergic disease reaction likely exacerbate component vaccine ( ) . Major congenital defect serious chronic illness . History neurologic disorder seizure . Acute disease time enrolment . Other condition opinion investigator may potentially interfere interpretation study outcome . Administration immunoglobulins and/or blood product since birth plan administration study period .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>8 Weeks</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Tetanus</keyword>
	<keyword>Diphtheria</keyword>
	<keyword>Pertussis</keyword>
	<keyword>Haemophilus influenzae type b Vaccines</keyword>
</DOC>